The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Recursive partitioning for new classification of patients with esophageal cancer treated by chemoradiotherapy.
Motoo Nomura
No relevant relationships to disclose
Kohei Shitara
No relevant relationships to disclose
Takeshi Kodaira
No relevant relationships to disclose
Chihiro Kondoh
No relevant relationships to disclose
Daisuke Takahari
No relevant relationships to disclose
Takashi Ura
No relevant relationships to disclose
Hiroyuki Kojima
No relevant relationships to disclose
Minoru Kamata
No relevant relationships to disclose
Kei Muro
No relevant relationships to disclose
Satoshi Sawada
No relevant relationships to disclose